サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1786405

経皮毒性試験の世界市場

Dermal Toxicity Testing

出版日
ページ情報
英文 198 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.46円
経皮毒性試験の世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

経皮毒性試験の世界市場は2030年までに41億米ドルに達する見込み

2024年に27億米ドルと推定される経皮毒性試験の世界市場は、2024年から2030年にかけてCAGR 7.5％で成長し、2030年には41億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである経皮毒性試験サービスは、CAGR 8.9％を記録し、分析期間終了時には24億米ドルに達すると予測されます。経皮毒性試験製品セグメントの成長率は、分析期間中CAGR 5.6%と推定されます。

米国市場は6億9,910万米ドル、中国はCAGR 7.2％で成長すると予測

米国の経皮毒性試験市場は、2024年に6億9,910万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに6億5,460万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.1%と6.2%と予測されています。欧州では、ドイツがCAGR 5.8%で成長すると予測されています。

世界の経皮毒性試験市場- 主要動向と促進要因まとめ

なぜ経皮毒性試験の需要が急増しているのか？

世界の経皮毒性試験市場は、安全で効果的なスキンケア、医薬品、化学製品へのニーズの高まりにより、急成長を遂げています。米国食品医薬品局（FDA）や欧州化学品庁（ECHA）などの規制機関が厳しい安全基準を課す中、企業は自社製品が皮膚刺激や感作性、長期的な皮膚障害を引き起こさないことを保証しなければならないです。特に化粧品・パーソナルケア業界では、クルーエルティ・フリーや非動物実験製品への需要が急増し、代替手法の採用がさらに進んでいます。さらに、合成化学物質の潜在的な悪影響に対する消費者の意識の高まりが、メーカーに厳格な安全性評価を優先するよう促しています。皮膚科学研究の拡大と皮膚関連疾患の増加により、包括的な経皮毒性試験の需要は増加の一途をたどっています。

技術革新は経皮毒性試験市場をどのように変えているか？

技術の進歩は、経皮毒性試験の状況を大きく変え、より信頼性が高く、倫理的で、費用対効果の高いソリューションを導入しています。3Dヒト皮膚モデルのようなin vitro試験法の採用は、従来の動物実験に代わる優れた代替法を提供し、ヒトの皮膚反応をより高い精度で予測できるようになりました。さらに、ハイスループットスクリーニング（HTS）技術や高度なバイオインフォマティクスツールによって毒性解析が加速され、研究者は複数の化合物を同時に評価できるようになりました。毒性予測における人工知能（AI）と機械学習の統合は、データ解析をさらに強化し、毒性評価の効率と精度を向上させています。さらに、規制機関は、化学物質と皮膚の相互作用の仮想シミュレーションを可能にするインシリコ（コンピューターベース）モデリング技術を提唱するようになっています。このような技術的躍進が経皮毒性試験の未来を形作り、より安全で倫理的な製品開発を可能にしています。

経皮毒性試験市場に影響を与える主な課題は？

経皮毒性試験の分野での進歩にもかかわらず、いくつかの課題が経皮毒性試験の成長と標準化に影響を与え続けています。主な障害の一つは、ヒトの皮膚生物学の複雑さであり、普遍的に適用可能なin vitroモデルを作成することを困難にしています。動物実験に代わる代替的な方法は進歩しているもの、規制当局による検証や世界の普及には時間がかかり、これらのモデルの普及を遅らせています。さらに、高度な試験技術に関連する高コストと熟練した専門家の必要性が、中小企業にとって財政的・経営的な障壁となっています。さらに、国によって安全規制が異なるため、多国籍企業にとってコンプライアンス上の課題が生じ、地域固有の試験要件に継続的に適合させる必要があります。規制の調和、調査への投資、費用対効果の高い技術革新の増加を通じてこれらの問題に対処することが、経皮毒性試験市場の持続的拡大には不可欠です。

経皮毒性試験市場の成長を促進する要因は？

経皮毒性試験市場の成長は、規制当局の監視の高まり、安全で倫理的な製品に対する消費者の需要の増加、代替検査手法の進歩など、いくつかの要因によって牽引されています。in vitroおよびin silico試験手法の採用が拡大していることに加え、AIを活用した予測モデリングにより、毒性評価の信頼性と効率が向上しています。さらに、製薬、化粧品、化学産業の拡大により、厳格な安全性評価の必要性が高まっており、市場の成長を後押ししています。政府の規制や擁護団体に支えられた無残酷試験の推進は、動物試験法からの移行を加速させています。さらに、研究資金の増加や、規制当局と民間団体との共同研究が、革新的なソリューションの開発を促進しています。絶え間ない技術の進歩と安全性への関心の高まりにより、市場は今後数年間で持続的な成長を遂げる態勢が整っています。

セグメント

タイプ（経皮毒性試験サービス、経皮毒性試験製品）、試験方法（インビトロ試験方法、インビボ試験方法、インシリコモデリング試験方法）、試験タイプ（皮膚感作性試験、皮膚刺激性試験、皮膚腐食性試験、光毒性試験）、エンドユーザー（ヘルスケア産業エンドユーザー、化粧品およびパーソナルケア製品エンドユーザー、化学エンドユーザー、その他エンドユーザー）

調査対象企業の例

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Covance Inc.（now part of Labcorp）
  • Cyprotex（a subsidiary of Evotec SE）
  • Eurofins Scientific Inc.
  • Evotec SE
  • GE Healthcare
  • Intertek Group plc
  • InVivo Biosystems
  • MatTek Corporation
  • Merck KGaA
  • Promega Corporation
  • Qiagen N.V.
  • QIMA Ltd.
  • Quest Diagnostics Incorporated
  • SGS S.A.
  • Thermo Fisher Scientific Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP30443

Global Dermal Toxicity Testing Market to Reach US$4.1 Billion by 2030

The global market for Dermal Toxicity Testing estimated at US$2.7 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Dermal Toxicity Testing Services, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Dermal Toxicity Testing Products segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$699.1 Million While China is Forecast to Grow at 7.2% CAGR

The Dermal Toxicity Testing market in the U.S. is estimated at US$699.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$654.6 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Dermal Toxicity Testing Market - Key Trends & Drivers Summarized

Why Is The Demand For Dermal Toxicity Testing Increasing Rapidly?

The global dermal toxicity testing market is experiencing rapid growth due to the rising need for safe and effective skincare, pharmaceuticals, and chemical products. As regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Chemicals Agency (ECHA) impose stringent safety standards, companies must ensure that their products do not cause skin irritation, sensitization, or long-term dermal damage. The cosmetics and personal care industry, in particular, has witnessed a surge in demand for cruelty-free and non-animal-tested products, further driving the adoption of alternative dermal toxicity testing methods. Additionally, increasing consumer awareness of the potential adverse effects of synthetic chemicals has encouraged manufacturers to prioritize rigorous safety evaluations. With the expanding landscape of dermatological research and the rise in skin-related disorders, the demand for comprehensive dermal toxicity testing continues to grow.

How Are Technological Innovations Transforming The Dermal Toxicity Testing Market?

Technological advancements have significantly revolutionized the dermal toxicity testing landscape, introducing more reliable, ethical, and cost-effective solutions. The adoption of in vitro testing methods, such as 3D human skin models, has provided a superior alternative to traditional animal testing, offering higher accuracy in predicting human skin reactions. Additionally, high-throughput screening (HTS) techniques and advanced bioinformatics tools have accelerated toxicity analysis, allowing researchers to assess multiple compounds simultaneously. The integration of artificial intelligence (AI) and machine learning in toxicity prediction has further enhanced data analysis, improving efficiency and precision in toxicity assessment. Furthermore, regulatory bodies are increasingly advocating for in silico (computer-based) modeling techniques, which enable virtual simulations of skin interactions with chemicals. These technological breakthroughs are shaping the future of dermal toxicity testing, ensuring safer and more ethical product development.

What Are The Major Challenges Affecting The Dermal Toxicity Testing Market?

Despite the progress in the field, several challenges continue to affect the growth and standardization of dermal toxicity testing. One of the primary obstacles is the complexity of human skin biology, making it difficult to create universally applicable in vitro models. While alternative methods have made strides in replacing animal testing, regulatory validation and global acceptance of these models remain slow, delaying widespread adoption. Additionally, the high costs associated with advanced testing techniques and the need for skilled professionals pose financial and operational barriers for smaller companies. Moreover, discrepancies in safety regulations across different countries create compliance challenges for multinational businesses, necessitating continuous adaptation to region-specific testing requirements. Addressing these issues through increased regulatory harmonization, investment in research, and cost-effective innovations will be essential for the sustained expansion of the dermal toxicity testing market.

What Factors Are Driving The Growth Of The Dermal Toxicity Testing Market?

The growth in the dermal toxicity testing market is driven by several factors, including rising regulatory scrutiny, increasing consumer demand for safe and ethical products, and advancements in alternative testing methodologies. The growing adoption of in vitro and in silico testing approaches, along with AI-driven predictive modeling, has enhanced the reliability and efficiency of toxicity assessments. Additionally, the expansion of the pharmaceutical, cosmetic, and chemical industries has intensified the need for stringent safety evaluations, propelling market growth. The push for cruelty-free testing, backed by government regulations and advocacy groups, has accelerated the transition away from animal testing methods. Furthermore, increased research funding and collaborations between regulatory agencies and private organizations are fostering the development of innovative dermal toxicity testing solutions. With continuous technological progress and a rising focus on safety, the market is poised for sustained growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Dermal Toxicity Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Dermal Toxicity Testing Services, Dermal Toxicity Testing Products); Testing Method (In-Vitro Testing Method, In-Vivo Testing Method, In-Silico Modeling Testing Method); Test Type (Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests, Phototoxicity Tests); End-Use (Healthcare industry End-Use, Cosmetics and Personal Care Products End-Use, Chemical End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Covance Inc. (now part of Labcorp)
  • Cyprotex (a subsidiary of Evotec SE)
  • Eurofins Scientific Inc.
  • Evotec SE
  • GE Healthcare
  • Intertek Group plc
  • InVivo Biosystems
  • MatTek Corporation
  • Merck KGaA
  • Promega Corporation
  • Qiagen N.V.
  • QIMA Ltd.
  • Quest Diagnostics Incorporated
  • SGS S.A.
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Dermal Toxicity Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Cosmetic and Pharmaceutical Product Safety Throws the Spotlight on Dermal Toxicity Testing
    • Global Regulatory Compliance Requirements Spur Adoption of In Vitro and Alternative Testing Models
    • Shift Away from Animal Testing Strengthens the Business Case for Reconstructed Human Epidermis Models
    • Growth of Personal Care, Chemical, and Agrochemical Sectors Drives Expanded Testing Pipelines
    • Technological Innovation in Skin-on-a-Chip and Microfluidic Models Enhances Accuracy and Scalability
    • Increased Use of Predictive Toxicology and AI-Driven Screening Supports Non-Animal Safety Assessment
    • OECD and REACH Guidelines Shape Standardized Testing Protocols for Global Market Access
    • Emerging Demand for Rapid Toxicity Screening Tools Fuels Investment in High-Throughput Platforms
    • Expansion of Toxicity Testing in Nanomaterials and Biologics Creates Demand for Specialized Protocols
    • Growing Pharmaceutical Outsourcing Trends Drive Use of CROs and Contract Testing Laboratories
    • Consumer Advocacy and Ethical Branding Pressures Encourage Adoption of Cruelty-Free Testing Methods
    • Toxicology Data Integration with Risk Assessment Platforms Enhances Product Development Speed
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Dermal Toxicity Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Dermal Toxicity Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dermal Toxicity Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Dermal Toxicity Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Dermal Toxicity Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Dermal Toxicity Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Healthcare industry End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Healthcare industry End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cosmetics & Personal Care Products End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Cosmetics & Personal Care Products End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Chemical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Chemical End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for In-Vitro Testing Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for In-Vitro Testing Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for In-Vivo Testing Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for In-Vivo Testing Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for In-Silico Modeling Testing Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for In-Silico Modeling Testing Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Skin Sensitization Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Skin Sensitization Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Skin Irritation Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Skin Irritation Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Skin Corrosion Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Skin Corrosion Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Phototoxicity Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Phototoxicity Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • JAPAN
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • CHINA
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 54: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • EUROPE
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Dermal Toxicity Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • FRANCE
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 72: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • GERMANY
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • ITALY
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • UNITED KINGDOM
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 96: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030

IV. COMPETITION